Clinical trial
Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy
NCT00350688 · Ottawa Hospital Research Institute, Other · Terminated
Key facts
| NCT number | NCT00350688 |
|---|---|
| Title | Bladder Cancer Chemoradiation Using Intensity Modulated Radiation Therapy |
| Official title | Phase II Trial To Evaluate The Potential For Helical Tomotherapy IMRT To Improve Bladder Cancer Chemoradiation |
| Lead sponsor | Ottawa Hospital Research Institute, Other |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Radiation |
| Interventions | Helical tomotherapy IMRT |
| Enrollment | 9 |
| Start date | Nov 1, 2005 |
| Primary completion | Apr 1, 2010 |
| Completion | Apr 1, 2010 |
| First posted | Jul 11, 2006 |
| Last update posted | Apr 17, 2020 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: